SubHero Banner
Text

2nd Quarter 2017

Key topics in this quarter’s edition include:

  • Glecaprevir/pibrentasvir for the treatment of Hepatitis C virus infection
  • Sofosbuvir/velpatasvir/voxilaprevir for the treatment of Hepatitis C virus infection
  • Voretigene neparvovec for the treatment of Inherited retinal disease/ dystrophy

Download PDF

Text